November 9, 2016 PAP-Q1-16-IL-002
Customer perception describes how a current buyer or prospect rates a company based on the information they have been exposed to — from marketing materials to word-of-mouth influence, as well as experience with the company. Nice Insight uses six key drivers of outsourcing — quality, reliability, productivity, affordability, innovation and regulatory history — to measure customer perception; the number listed is the average of the six individual scores, down to the decimal point.
1. Worldwide Clinical Trials 87.33% CP Score Mean
2. ICON 86.33%
3. MPI Research 85.83%
4. BRI Biopharmaceutical Research 85.67%
5. PPD 85.50%
6. MedPace Inc. 85.33%
7. Toxikon Corporation 85.00%
8. Lambda Therapeutic Research 84.83%
9. American Preclinical Services 84.33%
9. JRF Global 84.33%
9. PRA Health Sciences 84.33%
1. Evotec 90.50% CP Score Mean
2. Worldwide Clinical Trials 88.67%
3. MPI Research 87.33%
4. CiToxLAB 87.00%
4. ICON 87.00%
6. Seventh Wave Laboratories 86.50%
7. Parexel 86.33%
8. JRF Global 85.83%
9. PRA Health Sciences 85.50%
10. Battelle 85.33%
1. Blue Sky BioServices 88.00% CP Score Mean
2. Quest Diagnostics Clinical Trials 87.33%
3. Seventh Wave Laboratories 86.50%
4. Parexel 86.33%
5. Evotec 85.67%
5. MicroConstants 85.67%
7. ICON 85.50%
7. MPI Research 85.50%
7. Surpass 85.50%
7. PRA Health Sciences 85.50%
1. Blue Sky BioServices 87.33% CP Score Mean
2. Novotech 87.00%
3. Quest Diagnostics Clinical Trials 86.83%
4. ICON 86.00%
4. Toxikon Corporation 86.00%
6. Evotec 85.83%
6. Smithers Avanza 85.83%
8. PRA Health Sciences 85.67%
8. CNS Network 85.67%
10. Surpass 85.50%
1. BASi 88.33% CP Score Mean
2. Blue Sky BioServices 87.67%
2. Worldwide Clinical Trials 87.67%
4. InnoPharma S.r.l. 87.50%
5. Parexel 87.00%
6. Evotec 86.83%
6. ICON 86.83%
8. PRA Health Sciences 86.67%
9. Quest Diagnostics Clinical Trials 86.33%
10. CiToxLAB 85.83%
10. Product Safety Labs 85.83%
1. Quest Diagnostics Clinical Trials 88.33% CP Score Mean
2. Novum Pharmaceutical Research Sciences 87.67%
3. InnoPharma S.r.l. 87.33%
4. CNS Network 87.17%
5. InVentiv Health 87.00%
6. ICON 86.50%
7. Parexel 85.83%
7. Worldwide Clinical Trials 85.83%
9. Novotech 85.50%
10. BioSkin GmbH 85.00%
10. Janix 85.00%
1. CNS Network 87.50% CP Score Mean
2. InnoPharma S.r.l. 87.17%
2. Janix 87.17%
4. Chiltern 86.83%
5. INC Research 86.17%
5. PRA Health Sciences 86.17%
5. Spaulding Clinical 86.17%
8. Novum Pharmaceutical Research Sciences 85.83%
9. MedPace Inc. 85.67%
10. Envigo 85.33%
1. InnoPharma S.r.l. 87.17% CP Score Mean
2. Worldwide Clinical Trials 86.67%
3. InVentiv Health 86.50%
4. Intertek 86.00%
5. PRA Health Sciences 85.67%
6. Parexel 85.50%
7. Novotech 85.33%
8. MedSource 85.17%
9. MedPace Inc. 84.83%
10. CNS Network 84.50%
10. ICON 84.50%
1. Parexel 88.67% CP Score Mean
2. InnoPharma S.r.l. 87.83%
3. Piramal Pharma Solutions 87.33%
4. Novum Pharmaceutical Research Sciences 87.17%
4. PRA Health Sciences 87.17%
6. MPI Research 86.83%
6. Novotech 86.83%
6. Premier Research 86.83%
6. Worldwide Clinical Trials 86.83%
10. BRI Biopharmaceutical Research 86.50%
1. Worldwide Clinical Trials 89.67% CP Score Mean
2. Piramal Pharma Solutions 88.00%
3. InnoPharma S.r.l. 86.50%
3. Blue Sky BioServices 86.50%
3. Janix 86.50%
6. SanaClis 86.33%
7. Quest Diagnostics Clinical Trials 86.17%
8. Spaulding Clinical 86.00%
9. MPI Research 85.67%
10. Rho 85.50%
Guy supports the success of life science organizations by identifying synergies across research, content, marketing and communications resources to drive value for clients. With over 30 years of education and marketing experience and 18 years in the life sciences alone, Guy leads our editorial standards for client content, Pharma’s Almanac and Nice Insight research-based industry content as well as external communications for clients. Having served as head of global marketing and communications for a CMO, he also brings critical insight and guidance to all communications. Guy holds a Masters degree from Columbia University.